Pat O’Sullivan
Geschäftsführer bei AMICUS THERAPEUTICS, INC.
Profil
Pat O’Sullivan currently works at Amicus Therapeutics, Inc., as Chief Technical Operations Officer from 2022.
Mr. O’Sullivan also formerly worked at Genzyme Therapeutics Ltd., as Vice President-Global Supply Chain from 2001 to 2022.
Mr. O’Sullivan received his Masters Business Admin degree from The Open University and undergraduate degree from Munster Technological University.
Aktive Positionen von Pat O’Sullivan
| Unternehmen | Position | Beginn |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Geschäftsführer | 01.07.2022 |
Ehemalige bekannte Positionen von Pat O’Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01.08.2022 |
Ausbildung von Pat O’Sullivan
| The Open University | Masters Business Admin |
| Munster Technological University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |